Compare stocks

Straumann Holding AG is a global company specializing in the manufacture and supply of dental implants, orthodontic products, and digital dentistry tools. Headquartered in Basel, Switzerland, the company's products include dental implants, prosthetics, digital equipment, and biomaterials, serving both dental professionals and patients worldwide. Straumann has grown through strategic acquisitions, expanding its footprint in digital and orthodontic technologies. The company operates in various international markets, leveraging a strong focus on innovation and partnerships to maintain its competitive advantage in the dental industry. Its strategic positioning is supported by a commitment to research and development, ensuring continuous advancements in dental solutions.

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.